Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Exelixis Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 16, 2021 / 03:20PM GMT
Release Date Price: $23.57 (-2.48%)
Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst

Hello, everyone, and welcome to Oppenheimer's 31st Annual Healthcare Conference. I'm Jay Olson, one of the biotech analysts at Oppenheimer, and I want to thank you all for joining us.

It's my pleasure to welcome Exelixis to our conference. And it's an honor to introduce Michael Morrissey, the CEO. (Operator Instructions) And with that, we'll get started. Thank you so much, Michael, for joining us.

Questions & Answers

Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst

I thought maybe we'd open up with a few questions about your strong 2020 results. You delivered solid fourth quarter performance with $200 million of sales of cabo. And your 2021 guidance of $1 billion in revenues implies 35% year-over-year growth.

Can you just maybe talk about what sort of assumptions you factored into your 2021 revenue guidance? And what kind of recovery from COVID are you seeing so far this year?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot